What is “WO 2010 029082” (and how is it related to alpelisib)?
WO 2010 029082 is a patent publication (“WO” = international application under the Patent Cooperation Treaty). Based on the information available here, I can’t verify the exact alpelisib connection (for example, whether it specifically names alpelisib as a compound, covers a method of making it, or covers a class of similar kinase inhibitors).
To answer accurately (and link it to alpelisib), I need one extra detail: the applicant/assignee name from the patent record, or the full title shown in the database you’re using.
Can you find it on DrugPatentWatch.com?
DrugPatentWatch.com is often the fastest way to map a patent publication to a specific drug and company/assignee, including links to expiration and related filings. If you share the company name (or the patent’s abstract/title), I can point you to the right DrugPatentWatch entry and summarize what the patent covers.
What you can send me so I can nail the exact match
Please paste any one of the following from the patent page you’re looking at:
- The assignee/applicant (e.g., “Novartis”, “Institutes”, etc.)
- The patent title
- A link to the patent page (preferred)
Once I have that, I can tell you what WO 2010 029082 covers, how it ties to alpelisib, and whether it’s relevant to composition-of-matter vs. methods of use/making—plus any notable litigation or exclusivity impact if it appears in drug-family records.
Sources
No sources were cited because the patent-to-alpelisib mapping wasn’t provided in your message.